DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gadoteridol
Gadoteridol
Radiopharmaceuticals and Contrast Media – Oxford Clinical Policy
Magnetic Resonance Imaging (MRI) Contrast Agents Frequently Asked Questions
ACR Manual on Contrast Media
Gadolinium Based Contrast Agents
DISSERTATION INVESTIGATION of CATIONIC CONTRAST-ENHANCED COMPUTED TOMOGRAPHY for the EVALUATION of EQUINE ARTICULAR CARTILAGE Su
Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017
Table of Contents
2012 CKD Guideline
Art. 31 Gadolinium
Drug Consumption at Wholesale Prices in 2017 - 2020
Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO
EMA's Final Opinion Confirms Restrictions on Use of Linear
Contrast Imaging
FDA Listing of Established Pharmacologic Class Text Phrases January 2021
Chapter 1: Introduction and Background…………………………………………….…...1
Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based
Gadolinium Containing Contrast Agents
Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: the Physio-Pathological Conditions for the Perfect Murder
Top View
Manual on Contrast Media Version 7 2010
Provisional Peer-Reviewed Toxicity Values for Stable (Nonradioactive) Gadolinium (Casrn 7440-54-2) and Soluble Salts
MEDICATION GUIDE PROHANCE® (Prō-ˈhan(T)S) (Gadoteridol)
Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
Safety and Clinical Usefulness of Gadoteric Acid Including Post-Marketing Surveillance
RCR Position Statement on the Revision of Marketing Authorisations
Repurposing Clinical Agents for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging: Current Status and Future Perspectives
Gadolinium-Containing Agents Restrictions on Use
115-14 Anonymisierter Beschluss
Special Report the Blood-Brain Barrier
Gadoteridol) Injection for Intravenous Use What Is PROHANCE? • PROHANCE Is a Prescription Medicine Called a Gadolinium-Based Contrast Agent (GBCA)
Contrast Dye Poster Back3
Pharmacokinetics Uses and Administration Adverse Effects And
201277Orig1s000
MRI-CEST Assessment of Tumour Perfusion Using X-Ray Iodinated Agents: Comparison with a Conventional Gd-Based Agent
Guidance on Gadolinium-Based Contrast Agent Administration to Adult Patients
Assessment Report
Bracco Imaging Customized Solutions Meet the Demands of an Evolving Radiology Market Company Commitment to Providing Products
12 MR Contrast Agents
Gbcas: Regulatory Update & Information on Guerbet's Products
204781Orig1s000
Medicines Adverse Reactions Committee
Application for Inclusion of Gadoterate Meglumine Pdf, 853Kb
17 Gadolinium Contrast Media for Radiographic Examinations Henrik S
Noninterpretive Skills Study Guide I Table of Contents, Continued
Resolution Ap (2000) 1
[Product Monograph Template
Pharmacology Part 5: Ct and Mri Contrast
Rules, Roles, and Room for Discussion in Gadoxetic Acid-Enhanced Magnetic Resonance Liver Imaging: Current Knowledge and Future Challenges